alexa

Search in Indianmoney's WealthPedia

 
Home News Biocon tumbles 3% on 5 USFDA observations for Bengaluru unit

Read more interesting news from around the globe with Indianmoney App

Google Play
 
Get the Best Financial Advice on Children Education PlanningClick Here
 
 
Biocon tumbles 3% on 5 USFDA observations for Bengaluru unit

Biocon tumbles 3% on 5 USFDA observations for Bengaluru unit

Monday, January 27, 2020, 7:44 PM

Shares of Biocon lost 2.8 percent intraday on January 27 after receiving five observations from the US health regulator for Bengaluru unit. The pharma company informed exchanges that the US FDA conducted a PAI and GMP inspection of the API manufacturing facility. It further said it would respond to the FDA with a CAPA and was confident of addressing these observations expeditiously.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

What is your Credit Score? Get FREE Credit Score in 1 Minute!

Get Start Now!
CIBIL Meter
Get It now!
Attention!

This is to inform that Suvision Holdings Pvt Ltd ("IndianMoney.com") do not charge any fees/security deposit/advances towards outsourcing any of its activities. All stake holders are cautioned against any such fraud.